REVIEW article
Front. Cardiovasc. Med.
Sec. Lipids in Cardiovascular Disease
This article is part of the Research TopicEvidence of Atherogenic Lipoproteins: what we gain from in vitro and in vivo researchView all 15 articles
Dysfunctional High-Density Lipoprotein: An Updated Review
Provisionally accepted- 1Texas Heart Institute at Baylor College of Medicine, Houston, United States
- 2National Center for Geriatrics and Welfare, National Health Research Institutes, Yunlin County, Taiwan
- 3Department of Child Care, National Pingtung University of Science and Technology Department of Biological Science and Technology, Pingtung, Taiwan
- 4Department of Internal Medicine, Division of Cardiology, Taipei Medical University, Taipei City, Taiwan
- 5Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
High-density lipoprotein (HDL) has earned its reputation as "good" cholesterol in cardiovascular health, primarily because of its strong inverse association with cardiovascular disease. A potential mechanism for this association is its ability to promote cholesterol efflux capacity (CEC) and consequently reduce the buildup of cholesterol in arterial plaque. However, recent research underscores the importance of not only maintaining high HDL cholesterol (HDL-C) levels but also ensuring the functionality and quality of HDL particles. HDL particles exhibit various other atheroprotective activities, including anti-inflammatory, antioxidant, and vasodilatory properties. Collectively, these functions are thought to contribute to reducing cardiovascular risk beyond mere cholesterol transport. Both acute and chronic inflammation can induce structural and functional changes in HDL, potentially rendering the particles pro-inflammatory. Factors that increase inflammation, such as lifestyle choices, autoimmune diseases, and oxidative stress, can adversely affect HDL functionality. Dysfunctional HDL, such as electronegative HDL H5 or HDL isolated from patients with cardiovascular disease (CVD), may lose its protective properties and even contribute to CVD progression by promoting inflammation, oxidative stress, and endothelial damage. Recent studies indicate that the CEC of HDL particles may serve as a more critical determinant of atheroprotection than the absolute concentration of HDL-C. This review emphasizes the need to focus on both quantity and quality of HDL to reduce cardiovascular risk more effectively. Understanding the mechanisms behind HDL's protective effects provide valuable insights into heart health and potential therapeutic strategies.
Keywords: dysfunctional, High-density lipoprotein (HDL), Electronegativity, Cardiovasculardisease, Inflammation, Oxidative Stress
Received: 25 Sep 2025; Accepted: 26 Nov 2025.
Copyright: © 2025 Ouyang, Chiang, Hsu, Tsai, Huang, Remaley, Akyol and CHEN. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Omer Akyol
CHU-HUANG CHEN
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
